Clostridium Difficile



Clostridium Difficile


Laura W. Lamps, MD










Endoscopic photograph shows characteristic pseudomembranes in a C. difficile infection. (Courtesy W. Webb, MD.)






Hematoxylin & eosin illustrates a low-power view of pseudomembranous colitis, showing dilated crypts that give rise to a laminated, volcano-like, mucopurulent exudate.


TERMINOLOGY


Abbreviations



  • Clostridium difficile (C. difficile)


Synonyms



  • Pseudomembranous colitis


Definitions



  • Infection by Clostridium difficile, potent toxigenic bacteria



    • Produces 2 toxins: Toxin A and toxin B


    • Causes colitis, most often pseudomembranous colitis


ETIOLOGY/PATHOGENESIS


Recent Prior Antibiotic Exposure



  • Usually orally administered antibiotics


  • Bacteria cannot infect in presence of normal gut flora


  • Most common nosocomial GI pathogen


Other Risk Factors



  • Elderly patients


  • Severe comorbid illness/admission to ICU



    • Inflammatory bowel disease


  • Indwelling nasogastric tubes


  • GI procedures


  • Antacids


  • Long hospitalization


CLINICAL ISSUES


Presentation



  • Diarrhea



    • Ranging from mild to severe


    • Initially watery


    • Variably bloody


  • Fever


  • Leukocytosis


  • Abdominal pain


  • Symptoms can occur weeks after stopping antibiotics


  • Complications



    • Toxic megacolon


    • Perforation


    • Reactive polyarthritis


  • Variant presentations



    • May be superimposed on IBD


    • Rare patients are asymptomatic


    • Patients with fulminant disease may have signs of acute abdomen but lack diarrhea


Treatment



  • Antibiotics, supportive care


  • Fulminant cases may require surgery


Prognosis

Jul 6, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Clostridium Difficile

Full access? Get Clinical Tree

Get Clinical Tree app for offline access